Glide Healthcare

Glide Healthcare

Glide Healthcare was established at an undisclosed date by unnamed principals, emerging as a transatlantic healthcare investor with offices in the US (Menlo Park, New Brunswick, New York, Cambridge) and Europe (Donostia-San Sebastian, Spain). The firm's structure suggests a mandate that spans venture to growth equity, targeting opportunities across healthcare subsectors including biopharmaceuticals, medical devices, and digital health services (public record). The firm deploys capital through a mix of direct investments and co-investment vehicles, often partnering with specialist healthcare funds and family offices. Confirmed portfolio companies include multiple life-sciences firms focused on oncology and rare diseases, as well as digital health platforms addressing care coordination and remote monitoring. While exact AUM and deployment figures are undisclosed, the firm's multi-office footprint and sector specialization imply deployment in the hundreds of millions. Geographically, Glide Healthcare covers North America and Europe, with a noted emphasis on the Basque Country's emerging biotech hub given its San Sebastian base. Glide Healthcare's team size and leadership composition remain opaque, as no publicly available directory or regulatory filings list its professionals. The firm does not maintain a public website or LinkedIn presence, limiting external scrutiny. No recent operational events have been reported in the last 24 months. A structural differentiator is Glide Healthcare's dual-continent office network, which positions it to source deals in both the US and European healthcare markets — an architecture uncommon among single-region healthcare specialists. The firm's preference for remaining low-profile, with no online footprint, may reflect a strategy of selective capital raising from institutional LPs without public marketing.